For Innovative Psychiatric Research


Depressed patients see quality of life improve with nerve stimulation

Study focuses on people not treated effectively with antidepressants

New approach to developing antidepressants

CRISPR technology helps target mood-boosting receptors in brain

Sage Therapeutics Reports Positive Top-line Results from Phase 2 Placebo-Controlled Trial of SAGE-217 in Major Depressive Disorder

Sage Therapeutics announced positive top-line results from the Phase 2

Sage Therapeutics Announces Brexanolone Achieves Primary Endpoints in Both Phase 3 Clinical Trials in Postpartum Depression

Sage therapeutics announced positive top-line results from two Phase 3 clinical trials with its proprietary i.v. formulation of brexanolone

Can laughing gas help deter suicide?

Researchers studying use of nitrous oxide for patients hospitalized for suicide risk

Caring for mom & baby

Children’s outcomes improve when perinatal mental health issues are addressed.

Hard-to-treat depression in seniors focus of $13.5 million study

Goal is to identify strategies most likely to work for specific patients

Nagele honored by Society of Biological Psychiatry

Award recognizes standout research published in the journal Biological Psychiatry

Exploring a new way to diagnose mental illness

New grant from the National Institute of Mental Health will fund study of structural and functional connectivity of patients with psychiatric disorders.

Laughing gas studied as depression treatment

Results from pilot study indicate improvement after receiving nitrous oxide in two-thirds of patients with treatment-resistant depression.

Your support to help cure and prevent psychiatric illness is vital. Join with us in our mission to help change the future.
Ways to Give